PremalignantLip SCC precursorICD-10 L57.0

Actinic cheilitis

Solar cheilitis ยท actinic cheilosis ยท cheilitis actinica chronica

Actinic cheilitis is the lip equivalent of actinic keratosis โ€” a UV-induced premalignant change of the vermilion border, most commonly the lower lip. Approximately 10-30% of cutaneous lower-lip SCCs arise on a background of actinic cheilitis, and lower-lip cSCC carries a higher metastatic potential than other sun-exposed cSCC. UK BAD 2020 cSCC guidelines and NICE NG12 stipulate vigilance and treatment of premalignant lip change. Management spans field treatments (5-FU, imiquimod, MAL-PDT) and surgical vermilionectomy for diffuse disease.

CurrentLast reviewed 16 May 2026
Clinical image of Actinic cheilitis
Actinic cheilitis. Image sourced from DermNet New Zealand. Used under CC BY-NC-ND 4.0. No endorsement implied.

Risk and significance

  • Cumulative UV-B damage; outdoor occupations (farmers, fishermen, sailors), light skin types, smoking.
  • Older adults; men predominate.
  • Lower lip far more commonly involved than upper lip (anatomic UV exposure).
  • 10-30% of lower-lip cSCC arise from actinic cheilitis; lower-lip cSCC has higher metastatic potential (~10-15% vs ~3-5% for other sun-exposed sites).
  • Lip cSCC is a high-risk BWH location regardless of stage.

Clinical features

  • Diffuse dryness, scaling, fissuring of lower-lip vermilion.
  • Loss of sharp vermilion-cutaneous border.
  • Atrophy, pallor, white plaques (leukoplakia) โ€” may overlie.
  • Focal erythema, scaling, induration, persistent ulceration โ†’ red flags for invasive cSCC.
  • Persistent crusts that bleed on removal.

Investigations

  • Skin biopsy of indurated / persistent / ulcerated areas to exclude invasive cSCC โ€” punch biopsy through the most clinically atypical area.
  • Mapping biopsies for diffuse disease before planning treatment.
  • Dermoscopy: scaly white-yellow background, telangiectasia; obliteration of normal vermilion architecture.
  • Review for tobacco / sun-protection counselling.

Differential diagnosis

  • Chronic cheilitis simplex โ€” drying / wind / habit-licking.
  • Allergic contact cheilitis โ€” lipsticks, toothpaste, mango / nickel.
  • Discoid lupus erythematosus of the lip โ€” atrophy, scarring, white striations.
  • Oral lichen planus โ€” reticulate Wickham striae extending intra-orally.
  • Cheilitis granulomatosa / Melkersson-Rosenthal.
  • Plasma cell cheilitis.
  • Invasive cSCC โ€” single firm nodule / ulcer on a background of actinic cheilitis.

Management

  • General: photoprotective lip balm SPF 30+; smoking cessation; trauma avoidance.
  • Field therapies for diffuse actinic cheilitis without invasive lesion:
    • 5-fluorouracil 5% cream, 1-2ร— daily for 2-4 weeks.
    • Imiquimod 5% cream 3ร— weekly for 4-6 weeks.
    • MAL-PDT (Metvix) โ€” typically two sessions one week apart.
    • Tirbanibulin 1% ointment (Klisyri) โ€” actinic keratosis indication.
  • Focal treatments:
    • Cryotherapy for discrete lesions.
    • Curettage and cautery / electrodessication.
    • CO2 / Er:YAG laser ablation.
  • Surgical:
    • Vermilionectomy (lip shave with mucosal advancement) for diffuse / recalcitrant disease โ€” definitive treatment with histological clearance.
    • Excision biopsy of any persistent thickened / ulcerated area.
  • Long-term photoprotection; clinical surveillance every 6-12 months.

References

  1. Salgueiro AP et al. Treatment of actinic cheilitis: a systematic review. Clin Oral Investig. 2019;23:2041-2053.
  2. Levi A et al. Risk factors for actinic cheilitis: a cross-sectional, observational study. J Eur Acad Dermatol Venereol. 2020;34:1290-1295.
  3. Keller B et al. Vermilionectomy: a modern approach. JPRAS. 2014;67:e213-e217.
  4. Keohane SG et al. British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020. Br J Dermatol. 2021;184(3):401-414.
  5. NICE NG12. Suspected cancer: recognition and referral. London: NICE; 2015 (last updated 15 April 2026).

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.